Vasile Daniel Balaban

gastroenterologist/endoscopist, mountain-lover, film addict, fighting #pancreaticcancer

[AJG - The American Journal of Gastroenterology @AmJGastro]

Ultraprocessed Grains and Risk of Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology Study
Narula, et al.

📕 https://t.co/G7jvFfOp2j

[Frontline Gastro @FrontGastro_BMJ]

🧠 Hepatic Encephalopathy Series (Part 1/4): Diagnosis

There is no single diagnostic test for overt hepatic encephalopathy (HE).

A practical 4-step approach:
1️⃣ Define the underlying liver disease
2️⃣ Characterise the neurological syndrome
3️⃣ Identify precipitants
4️⃣ Exclude alternative diagnoses

🔗 https://t.co/l8uEfsKrja

⚠️ Not every confused patient with cirrhosis has HE.

#FrontlineGastroenterology #Hepatology #Cirrhosis #HepaticEncephalopathy

@basl_events @heppharm @livernursing @LiverAHPs @Liver4Lifeuk @f4liverresearch @IQILS_Liver @LiverTrust @EASLedu @EASLnews @BritSocGastro @BavenoCoop @BCLC_group @ILCAnews @APASLnews @liverfellow @my_ueg @UKCPAGastro
@PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BSGtrainees @drkeithsiau @ebtapper @DrLChina @acv69cardenas @GeriKeane @jamesbmaurice @ClinicLiver

[UEGJ @UEGJournal]

⚖️ #Subcutaneous infliximab achieves higher tissue drug levels in #IBD

🔸Higher serum & tissue infliximab levels vs #IV therapy
🔸Tissue levels correlated with sustained remission and predicted outcomes better than serum levels

📖 #OpenAccess 👉 https://t.co/KmJ3XJrOCY

[Dr Nitin Jagtap @miNitinjagtap]

Curent guidel: STOP PPIs aftr EVL
New RCT @Gut_BMJ : rebleding 28% → 11.5% with PPIs.
All deaths in no-PPI group-rebleeding-related.
tim2rewrit #BavenoVII https://t.co/FS7lHFuBlH #GITwitter #Hepatology #PortalHypertension #LiverTwitter @EASLedu @AASLDtweets @BavenoConsensus

[Yuri Gorelik @GorelikYuri]

🛑RCT @AGA_CGH mod-to-sev UC - 8wk induction of VEDO+UPA vs mono-VEDO (no placebo👏)

Endoscopic remission (tough goal) 37.5% vs 15.1%‼️

Clinical remission 67% vs 40%‼️

AEs▶️7.5% vs 7%

https://t.co/XKAObyNYwd

[Nature Reviews Gastroenterology & Hepatology @NatRevGastroHep]

New online! Precision nutrition for the prevention and management of inflammatory bowel disease https://t.co/hcIVAOygdP

[Dra Elizabeth Barba @DraBarba]

Mistakes in abdominal distension !!!

[Antonio Facciorusso @AntonioFaccior6]

Online the special issue on pancreatic cystic lesions i had the honour to lead with @jorgemachicado

Thanks to the experts involved such as @SN_gastro @chiaro_del @lelecapurso @KM_Pawlak @CrinoStefano @Samanta_JayPGI @DharJahnvi @PepiDellAnna @Gio_Marchegiani @som_krishna

[JOGS @JournalofGISurg]

AI-driven radiomics shows strong promise in detecting pancreatic cancer (#PDAC) in high- risk patients, with pooled sensitivity of 88% and specificity of 93% across nearly 15K patients
https://t.co/98htzE4JRT

[Dr Rupam Manna MD @DrRupamOncology]

🔬 Peripheral Blood Smear (PBS) — the “poor man’s bone marrow” 🩸

A simple smear can reveal:
✅ Leukemia
✅ Hemolysis
✅ DIC/TTP
✅ Nutritional anemia
✅ Infections like malaria
✅ Platelet disorders
✅ Marrow infiltration

From schistocytes to smudge cells, PBS remains one of the most powerful bedside hematology tools for rapid diagnosis and clinical correlation.

Early clues. Faster diagnosis. Better outcomes.

#PeripheralBloodSmear #PBS #Hematology #Leukemia #AML #CLL #CML #Anemia #Pathology #MedicalOncology #Oncology #MedEd #FOAMed #InternalMedicine #MedicalEducation #DrRupamManna

[Vasile Daniel Balaban @_vbalaban]

@docdhir The enhancing mural nodule is a significant high-risk feature, considering also the young age of the patient, surgery is advised by guidelines. But sometimes the surgeon is hard to convince in such cases.

[EndoCollab™ | GI Endoscopy Community @EndoCollabcom]

🪨 Bouveret’s versus 🆚
🪨 Mirizzi

by María Paula Forero, MD

[Joaquín Rodríguez | 🔎Endoscopia digestiva @joakirodriguez]

Un algoritmo detecta el 73% de cánceres de páncreas en TAC rutinarios hasta 3 AÑOS antes del diagnóstico. El doble que los radiólogos sin IA. Esto no es futuro, está pasando ahora.

https://t.co/YiMNhm6MeX

#CáncerPáncreas #IA #DiagnósticoPrecoz

[Keith Siau @drkeithsiau]

Management of peptic ulcer bleeding - updated ESGE guidelines unveiled at #ESGEDays2026 🩸🆕

📸: https://t.co/snEb1bOO9z

[A pancreatic cancer doctor @DanZhaoMD]

Pancreatic cancer | Nature Reviews Disease Primers https://t.co/tSW51s66jA

[Keith Siau @drkeithsiau]

Here are some of the highlights ‼️

1️⃣ Where to take photos
2️⃣ How to describe lesions
3️⃣ Barrett’s assessment
4️⃣ Gastric intestinal metaplasia

📸: @FrontGastro_BMJ
https://t.co/dW3kKoS1p3

[Gorka Orive @gorka_orive]

Un sistema de detección temprana basado en Inteligencia Artificial es capaz de detectar el cáncer de páncreas oculto mejor (73 vs 39%) que usando el TAC de los servicios de radiología. https://t.co/rbRg5ZMkUZ

[Enrique de-Madaria @DeMadaria]

Next-generation AI for visually occult pancreatic cancer detection in a low-prevalence setting with longitudinal stability and multi-institutional generalisability @Gut_BMJ

So interesting!
👇🏻👇🏻👇🏻
https://t.co/TmsZLP8Fo7

[robert verdonk @rcverdonk]

Very relevant work: EUS prior to MDT as default in IPMN?? 👉🏻The Impact of Endoscopic Ultrasound and Multidisciplinary Team Evaluation on the Management of Pancreatic Cystic Lesions - Dbouk - 2026 - United European Gastroenterology Journal https://t.co/P86sviM01U

[AJG - The American Journal of Gastroenterology @AmJGastro]

Patient Perspectives on Artificial Intelligence in Gastroenterology: A Multicenter Survey of Knowledge, Concerns, and Beliefs
Jahagirdar, et al.

📕 https://t.co/AGdhAAoMY6

@MLongMD @JasmohanBajaj